✦ LIBER ✦

Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor

✍ Scribed by M. Endo; K. Usuki; K. Kitazume; K. Iwabe; Y. Okuyama; A. Urabe

Publisher: Springer
Year: 1995
Tongue: English
Weight: 780 KB
Volume: 71
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf01697986

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hodgkin's disease producing granulocyte

Hodgkin's disease producing granulocyte colony stimulating factor

✍ Kazuyuki Shimizu; Minako Iida; Satoru Takahashi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Sweet's syndrome associated with sargram

Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment

✍ Geetika Kumar; Jack M. Bernstein; Jill S. Waibel; Michael A. Baumann 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

## Abstract Sweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim, a drug that causes increased neutrophil proliferation and differentiation. This complication has not previously been reported during treatment with sargramostim

Granulocyte—macrophage colony-stimulatin

Granulocyte—macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome

📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

Recombinant human granulocyte macrophage

Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in hodgkin's disease

✍ Dr A. M. Oza; M. Leahy; E. Dorey; C. L. Davis; J. Amess; M. Horton; A. Z. S. Roh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Fourteen patients with Hodgkin's disease (two previously untreated, 12 following relapse or with refractory disease) were treated with a combination chemotherapy regimen comprising chlorambucil, vinblastine, procarbazine, prednisolone, etoposide, vincristine and adriamycin administered on days 1-8.

Treatment with granulocyte-macrophage co

Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome

✍ Dr. Gregor Verhoef; Marc Boogaerts 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

We report a case of a patient who developed a fatal adult respiratory distress syndrome (ARDS) during treatment with rh granulocyte-macrophage colony stimulating factor (rhGM-CSF) (250 mcg/m2/day s.c.) and low-dose cytosine-arabinoside (Ara-C) (20 mg/ m2/day s.c.). Several mechanisms which might exp

Hypereosinophilic syndrome treated with

Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity

✍ Dr. Per Boye Hansen; Hans E. Johnsen; Erik Hippe 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

A 34-year-old male with hypereosinophilic syndrome (HES) and cardiac complications was treated with recombinant human a-interferon (rhlFN) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in the attempt to suppress the eosinophilic cell clones and stimulate the neutrophil myelop